About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Denver | 163 Studies

Clinical Trials Colorectal CancerDenver

Colorectal Cancer Clinical Trials in Denver

Find 163 clinical trials for colorectal cancer near Denver, Colorado. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Denver

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 163 trials

TerminatedStudy of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal CancerA Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS mutated unresectable, locally…NCT05631574·Goodyear, Arizona and 22 others CompletedOxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal CancerRATIONALE: Drugs used in chemotherapy, such as oxaliplatin, fluorouracil, leucovorin, and capecitabine, work in different ways to stop tumor cells from dividing so they stop…NCT00062426·Birmingham, Alabama and 51 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors TypesThis is a Phase 1a/1b, open-label, multicenter dose escalation and dose expansion clinical study to evaluate the safety, PK, immunogenicity and preliminary efficacy of IDE034 in…NCT07503808·Duarte, California and 25 others

CompletedAn Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has SpreadThis purpose of this study is to evaluate nivolumab (BMS-936558) in combination with standard of care (SOC) chemotherapy with bevacizumab for the treatment of first-line…NCT03414983·Birmingham, Alabama and 48 others

CompletedPromoting Colorectal Cancer Screening in Rural ColoradoThis community based participatory research study involves multicomponent educational interventions.NCT00137592·Denver, Colorado

CompletedOpen-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal CancerThe objective of this trial is to evaluate the safety and tolerability of BI 695502 in combination with leucovorin/5-fluorouracil/oxaliplatin (mFOLFOX6) and as maintenance therapy…NCT02776683·Phoenix, Arizona and 45 others

CompletedCombination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006786·Scottsdale, Arizona and 76 others

Active not recruitingA Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal CancerThe primary objective of the Phase 2 portion of the study is to characterize the clinical activity of maintenance therapy with GRT-C901/GRT-R902 (patient-specific vaccines) in…NCT05141721·Gilbert, Arizona and 42 others

Active not recruitingA Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid TumorsSolid tumours are abnormal lumps of tissue that can occur in different parts of the body.NCT06710847·Los Angeles, California and 21 others

Active not recruitingA Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)This is a first-in-human study evaluating the anti-T cell immunoglobulin and mucin containing protein-3 (TIM-3) antibody TSR-022.NCT02817633·Goodyear, Arizona and 88 others

TerminatedFOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal CancerThe purpose of the Phase Ib portion is to find out the highest dose of study drug that can safely be given when tested in a small group of subjects.NCT01133990·Denver, Colorado and 33 others

CompletedPhotodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver MetastasesThe purpose of this study is to determine whether the Litx platform is safe and effective in the treatment of liver metastasis arising from colorectal cancer.NCT00068068·Denver, Colorado and 5 others

Active not recruitingFinancial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing TreatmentThis research trial studies the financial burden in patients with stage I-III colon or rectal cancer who are undergoing treatment.NCT03516942·Anchorage, Alaska and 715 others

CompletedA Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal CancerThis is a Phase 2, open-label, 2-part, multicenter study in subjects with MSS relapsed/refractory colorectal cancer.NCT03258398·Scottsdale, Arizona and 6 others

CompletedPhase 1 and 2 Study of PX-866 and CetuximabThe purpose of this Phase 1/2 open-label study is to determine the safety and efficacy of a cetuximab and PX-866 combination treatment.NCT01252628·Birmingham, Alabama and 39 others

CompletedIrinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00012389·Huntsville, Alabama and 153 others

TerminatedStudy of Ruxolitinib in Colorectal Cancer PatientsThe purpose of this study was to determine if ruxolitinib, in combination with regorafenib, is safe and effective in the treatment of metastatic colorectal cancer.NCT02119676·Chandler, Arizona and 85 others

Active not recruitingTucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal CancersThis trial studies tucatinib to find out if it is safe when given with trastuzumab and other anti-cancer drugs (pembrolizumab, FOLFOX, and CAPOX).NCT04430738·Phoenix, Arizona and 26 others

CompletedStudy of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal CancerThe purpose of this study is to determine whether overall survival is prolonged in subjects with metastatic, epidermal growth factor receptor (EGFR)-positive colorectal cancer…NCT00063141·Tucson, Arizona and 187 others

Active not recruitingMOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid TumorsThe main purpose of this study is to assess safety \& tolerability and antitumor activity of LY3962673 as monotherapy and in combination with other chemotherapy agents in…NCT06586515·Duarte, California and 51 others

PreviousPage 3 of 9Next

Other Conditions in Denver

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma